|
Volumn 18, Issue 1, 2008, Pages 418-422
|
Discovery of an orally efficaceous 4-phenoxypyrrolidine-based BACE-1 inhibitor
|
Author keywords
Secretase inhibitors; Alzheimer's disease; Aspartyl proteases
|
Indexed keywords
4 PHENOXYPYRROLIDINE DERIVATIVE;
AMIDE;
AMINE;
AMYLOID BETA PROTEIN[1-40];
BETA AMYLOID CONVERTING ENZYME 1;
BETA AMYLOID CONVERTING ENZYME 1 INHIBITOR;
BETA AMYLOID CONVERTING ENZYME 2;
BETA SECRETASE INHIBITOR;
CATHEPSIN D;
CATHEPSIN E;
PEPSIN A;
PYRROLIDINE DERIVATIVE;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
AREA UNDER THE CURVE;
ARTICLE;
CRYSTAL STRUCTURE;
DISTRIBUTION VOLUME;
DRUG CLEARANCE;
DRUG DOSE INCREASE;
DRUG EFFICACY;
DRUG SCREENING;
HUMAN;
HUMAN CELL;
HYDROGEN BOND;
IC 50;
MOUSE;
NONHUMAN;
RAT;
STRUCTURE ACTIVITY RELATION;
X RAY CRYSTALLOGRAPHY;
ADMINISTRATION, ORAL;
AMIDES;
AMYLOID PRECURSOR PROTEIN SECRETASES;
ANIMALS;
ASPARTIC ENDOPEPTIDASES;
CRYSTALLOGRAPHY, X-RAY;
HUMANS;
HYDROGEN BONDING;
MICE;
MICE, TRANSGENIC;
MODELS, MOLECULAR;
PHENOLS;
PROTEASE INHIBITORS;
PYRROLIDINES;
RATS;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 37549069915
PISSN: 0960894X
EISSN: None
Source Type: Journal
DOI: 10.1016/j.bmcl.2007.10.053 Document Type: Article |
Times cited : (64)
|
References (20)
|